Posted November 22, 2019
With clot-busting aspirin tablets having fallen from grace, heart researchers are now having second thoughts about stents that prop open narrowed or blocked coronary arteries. For inexplicable reasons, the FDA approves medical devices like stents before they are fully vetted. Read more.